基于“治痿独取阳明”理论探讨针刺治疗慢性肾脏病肌少症作用机制
Exploring the Mechanism of Acupuncture Treatment for Sarcopenia in Chronic Kidney Disease Based on the Theory of “Exclusive Focus on Yangming Meridians for Treating Flaccidity”
DOI: 10.12677/acm.2025.1561742, PDF,   
作者: 杨庆鑫:黑龙江中医药大学研究生院,黑龙江 哈尔滨;于思明*:黑龙江中医药大学附属第一医院肾病二科,黑龙江 哈尔滨
关键词: 针灸慢性肾脏病肌少症治痿独取阳明Acupuncture Chronic Kidney Disease (CKD) Sarcopenia Exclusive Focus on Yangming Meridians for Treating Flaccidity
摘要: 随着人口老龄化的进程加重,慢性肾脏病(chronic kidney disease, CKD)已然成为了当代重要的公共健康挑战。在长期发病过程中,由于胰岛素抵抗、激素紊乱、肠道菌群失调等多种因素导致蛋白质降解增加,合成减少,机体呈负氮平衡,致使肌肉力量或肌肉功能降低,日久易合并肌肉减少症,“治痿独取阳明”理论源自《黄帝内经》,强调阳明经在痿证治疗中的关键作用。肌少症在中医理论中可归属于“痿证”范畴,与阳明经气血不足、筋脉失养密切相关。基于此,从“治痿独取阳明”理论出发,探讨针刺治疗慢性肾脏病肌少症的作用机制,有望为临床治疗提供新的思路和方法,具有重要的理论和实践意义。
Abstract: With the increasing aging of the population, chronic kidney disease (CKD) has become a significant public health challenge in modern times. During its long-term course, multiple factors such as insulin resistance, hormonal disorders, and gut microbiota dysregulation lead to increased protein degradation, reduced synthesis, and negative nitrogen balance in the body, resulting in decreased muscle strength or function. Over time, this predisposes to sarcopenia. The theory of “exclusive focus on Yangming meridians for treating flaccidity” originates from the Huangdi Neijing, emphasizing the critical role of the Yangming meridians in the treatment of flaccidity syndromes. Sarcopenia can be categorized into the “flaccidity syndrome” in traditional Chinese medicine (TCM) theory, which is closely associated with qi-blood deficiency in the Yangming meridians and inadequate nourishment of the tendons and vessels. Based on this theoretical framework, exploring the mechanism of acupuncture treatment for CKD-related sarcopenia from the perspective of “exclusive focus on Yangming meridians for treating flaccidity” is expected to provide new insights and methods for clinical intervention, holding important theoretical and practical significance.
文章引用:杨庆鑫, 于思明. 基于“治痿独取阳明”理论探讨针刺治疗慢性肾脏病肌少症作用机制[J]. 临床医学进展, 2025, 15(6): 421-426. https://doi.org/10.12677/acm.2025.1561742

参考文献

[1] 苗译亓. 慢性肾脏病并发肌少症的治疗研究进展[J]. 中外医学研究, 2024, 22(35): 181-184.
[2] Wilkinson, T.J., Miksza, J., Yates, T., Lightfoot, C.J., Baker, L.A., Watson, E.L., et al. (2021) Association of Sarcopenia with Mortality and End‐Stage Renal Disease in Those with Chronic Kidney Disease: A UK Biobank Study. Journal of Cachexia, Sarcopenia and Muscle, 12, 586-598. [Google Scholar] [CrossRef] [PubMed]
[3] Chatzipetrou, V., Bégin, M., Hars, M. and Trombetti, A. (2021) Sarcopenia in Chronic Kidney Disease: A Scoping Review of Prevalence, Risk Factors, Association with Outcomes, and Treatment. Calcified Tissue International, 110, 1-31. [Google Scholar] [CrossRef] [PubMed]
[4] Pereira, R.A., Cordeiro, A.C., Avesani, C.M., Carrero, J.J., Lindholm, B., Amparo, F.C., et al. (2015) Sarcopenia in Chronic Kidney Disease on Conservative Therapy: Prevalence and Association with Mortality. Nephrology Dialysis Transplantation, 30, 1718-1725. [Google Scholar] [CrossRef] [PubMed]
[5] Zhou, Y., Hellberg, M., Svensson, P., Höglund, P. and Clyne, N. (2017) Sarcopenia and Relationships between Muscle Mass, Measured Glomerular Filtration Rate and Physical Function in Patients with Chronic Kidney Disease Stages 3-5. Nephrology Dialysis Transplantation, 33, 342-348. [Google Scholar] [CrossRef] [PubMed]
[6] Abro, A., Delicata, L., Vongsanim, S. and Davenport, A. (2018) Differences in the Prevalence of Sarcopenia in Peritoneal Dialysis Patients Using Hand Grip Strength and Appendicular Lean Mass: Depends Upon Guideline Definitions. European Journal of Clinical Nutrition, 72, 993-999. [Google Scholar] [CrossRef] [PubMed]
[7] da Silva, M.Z.C., Vogt, B.P., Reis, N.S.d.C. and Caramori, J.C.T. (2019) Update of the European Consensus on Sarcopenia: What Has Changed in Diagnosis and Prevalence in Peritoneal Dialysis? European Journal of Clinical Nutrition, 73, 1209-1211. [Google Scholar] [CrossRef] [PubMed]
[8] Hotta, C., Hiraki, K., Wakamiya, A., Otobe, Y., Watanabe, S., Izawa, K.P., et al. (2015) Relation of Physical Function and Physical Activity to Sarcopenia in Hemodialysis Patients: A Preliminary Study. International Journal of Cardiology, 191, 198-200. [Google Scholar] [CrossRef] [PubMed]
[9] Gungor, O., Ulu, S., Hasbal, N.B., Anker, S.D. and Kalantar‐Zadeh, K. (2021) Effects of Hormonal Changes on Sarcopenia in Chronic Kidney Disease: Where Are We Now and What Can We Do? Journal of Cachexia, Sarcopenia and Muscle, 12, 1380-1392. [Google Scholar] [CrossRef] [PubMed]
[10] 杜亚婷, 宣铭杨, 饶向荣. 中西医结合防治慢性肾脏病肌少症[J]. 中国中西医结合杂志, 2023, 43(10): 1268-1272.
[11] 于思明, 苑芳. 针灸治疗慢性肾脏病的作用机制研究进展[J]. 中医药导报, 2016, 22(16): 98-99, 106.
[12] 章莹, 余建玮, 王飞. 基于《黄帝内经》理论谈国医大师伍炳彩辨治痿证经验[J]. 中华中医药杂志, 2020, 35(10): 4996-4998.
[13] 鞠申丹, 宗蕾. 从“治痿独取阳明”谈痿证的针灸治疗[J]. 中国针灸, 2015, 35(9): 956-959.
[14] 熊继柏. 熊继柏讲《内经》[M]. 长沙: 湖南科学技术出版社, 2016: 408.
[15] 刘学军. 慢性肾脏病与肌少症[J]. 中国实用内科杂志, 2022, 42(8): 634-637.
[16] 刘碧原, 王景信, 张艳, 等. 痿三针联合康复训练改善肌少症下肢运动功能和平衡及步行能力[J]. 临床研究, 2020, 28(10): 136-137.
[17] 周晶玲, 刘飞, 陈国超, 等. 热敏灸治疗新型冠状病毒肺炎后肌少症的疗效观察[J]. 上海针灸杂志, 2021, 40(9): 1059-1063.
[18] 杨靖, 黄英, 李娟. 温针灸治疗维持性血液透析患者肌少症的疗效观察及对血清Irisin和TNF-α的影响[J]. 上海针灸杂志, 2022, 41(12): 1195-1199.